The presence of proinflammatory cytokines, such as IL-6, IL-1, and TNF-α, has been linked to the pathogenesis of insulin resistance and endothelial dysfunction in metabolic syndrome, contributing to the presence of diffuse subclinical inflammation [50,51]. This evidence concerns the gene IL6 and Insulin resistance.